BSE: CIPLA - Cipla Limited

Lønnsomhet i seks måneder: -11.93%
Utbytte: +0.55%

Kampanjeplan Cipla Limited

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Cipla Limited

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments.

flere detaljer
It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

ISIN INE059A01026
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.5498
Дивиденд ао 13
Сайт https://www.cipla.com
Цена ао 1461.6
Prisendring per dag: 0% (1461.6)
Prisendring per uke: +0.2022% (1458.65)
Prisendring per måned: +0.8139% (1449.8)
Prisendring over 3 måneder: +0.9846% (1447.35)
Prisendring over seks måneder: -11.93% (1659.65)
Prisendring per år: -2.37% (1497.05)
Prisendring over 3 år: +48.12% (986.8)
Prisendring over 5 år: +227.05% (446.9)
Prisendring over 10 år: 0% (1461.6)
Prisendring siden begynnelsen av året: -0.7369% (1472.45)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 4.7 3
P/BV 4.46 4
P/E 29.01 6
EV/EBITDA 17.88 6
Total: 6

Effektivitet

Navn Betydning Karakter
ROA, % 13.26 4
ROE, % 16.45 5
Total: 4.83

Utbytte

Navn Betydning Karakter
Div yield, % 0.5498 1.38
DSI 1 10
Total: 3.84

Plikt

Navn Betydning Karakter
Debt/EBITDA 0.0724 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 51.23 7
Lønnsomhet Ebitda, % 49.05 6
Lønnsomhet EPS, % 166.18 10
Total: 7.6
Flere detaljer

Veileder Stillingstittel Betaling Fødselsår
Dr. Raju Sunil Mistry M.A., Ph.D. President & Global Chief People Officer N/A 1965 (60 år)
Mr. Pradeep Bhadauria President & Global Chief Scientific Officer N/A
Mr. Ashish Adukia Global Chief Financial Officer N/A
Mr. Dinesh Ramniranjan Jain Senior VP & Head of Corporate Finance N/A
Mr. Naveen Bansal Head of Investor Relations N/A
Mr. Rajendra Kumar Chopra Compliance Officer & Company Secretary 15.3M
Ms. Heena Kanal Senior Vice-President of Corporate Communications N/A
Mr. Umang Vohra B.E., M.B.A. MD, Global CEO & Executive Director 1971 (54 år)
Ms. Sneha Hiranandani B Com Chief Information Officer
Dr. Jaideep A. Gogtay M.D., Ph.D. Global Chief Medical Officer 1967 (58 år)

Adresse: India, Mumbai, Cipla House - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.cipla.com